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ABSTRACT
Reduced levels of the cardiac human (h)ERG ion channel protein and
the corresponding repolarizing current IKr can cause arrhythmia and
sudden cardiac death, but the underlying cellular mechanisms
controlling hERG surface expression are not well understood. Here,
we identified TRIOBP-1, an F-actin-binding protein previously
associated with actin polymerization, as a putative hERG-
interacting protein in a yeast-two hybrid screen of a cardiac library.
We corroborated this interaction by performing Förster resonance
energy transfer (FRET) in HEK293 cells and co-immunoprecipitation
in HEK293 cells and native cardiac tissue. TRIOBP-1 overexpression
reduced hERG surface expression and current density, whereas
reducing TRIOBP-1 expression via shRNA knockdown resulted
in increased hERG protein levels. Immunolabeling in rat
cardiomyocytes showed that native TRIOBP-1 colocalized
predominantly with myosin-binding protein C and secondarily with
rat ERG. In human stem cell-derived cardiomyocytes, TRIOBP-1
overexpression caused intracellular co-sequestration of hERG signal,
reduced native IKr and disrupted action potential repolarization. Ca2+
currents were also somewhat reduced and cell capacitance was
increased. These findings establish that TRIOBP-1 interacts directly
with hERG and can affect protein levels, IKr magnitude and cardiac
membrane excitability.
KEY WORDS: Yeast two-hybrid, TARA, IKr, iPSC-CM, FRET,
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INTRODUCTION
The coordinated activity of different ion conductances is the
foundation of signaling in excitable tissues (Hodgkin and Huxley,
1990). Nowhere is this more apparent than in the heart, where a
quantitative imbalance of depolarizing and repolarizing forces
can lead to arrhythmia and sudden cardiac death. Maintaining
normal excitability relies not only on specific gating and
selectivity properties of the ion channels involved but also on
their relative densities (Anderson et al., 2014; Milstein et al.,
2012). Although tremendous advances have been made in
understanding gating and selectivity, we know much less about
the complex mechanisms regulating channel density at the
plasma membrane.
Among the deadliest of cardiac arrhythmias are those associated
with long QT syndrome (LQTS), arising from inherited mutations in
as many as 15 genetic loci (for a review, see Bohnen et al., 2017).
One important target for inherited LQTS is the human ether-à-go-
go-related gene 1 (hERG; also known as KCNH2), which encodes
two subunits, hERG 1a and 1b, of the voltage-gated ion channels
that conduct the rapid delayed rectifier K+ current (IKr) (Sanguinetti
et al., 1995; Trudeau et al., 1995). These channels are also the
primary target of a more-prevalent, acquired form of LQTS in which
drugs intended for a diverse array of therapeutic targets inhibit IKr as
an off-target effect (Chiamvimonvat et al., 2017; Trudeau et al.,
1995). Despite advances identifying ion channel genes involved in
LQTS, over half of inherited arrhythmias do not map to known
disease loci (Hofman et al., 2013), suggesting that as-yet-
unidentified proteins account at least in part for the remaining
inherited LQTS cases.
In recent years, several cytoplasmic proteins have been identified
as components of macromolecular complexes with ion channels in
the heart. Among these are proteins that localize ion channels to
specialized cellular structures or regulate their target levels at the
surface membrane (Eichel et al., 2016; Kuo et al., 2001; Lowe et al.,
2008; Rosati et al., 2001; Sato et al., 2011; Vatta et al., 2006). For
example, Ca2+/calmodulin-associated serine kinase (CASK)
interacts with multiple channels and receptors, linking them with
the cytoskeleton, and even translocates to the nucleus where it
regulates gene expression (Eichel et al., 2016). N-cadherin
associates with Nav1.5 channels at intercalated discs, where the
association is proposed to facilitate both conduction of the electrical
signal and adhesion required for contraction of the myocardium
(Leo-Macias et al., 2016).
With the goal of finding proteins that regulate hERG channel
surface expression levels, we searched for cardiac proteins
interacting with hERG by using a yeast two-hybrid approach.
This screen identified an F-actin-binding protein associated with
actin polymerization, Trio-binding protein 1 (TRIOBP-1, a
alternative transcript encoded by TRIOBP) (Bradshaw et al.,
2014; Seipel et al., 2001). Here, by performing studies in
heterologous systems, native tissue and cardiomyocytes derived
from induced pluripotent stem cells, and applying an array of
techniques including Förster resonance energy transfer (FRET), co-
immunoprecipitation, whole-cell patch-clamp, and confocal and
stimulated emission depletion (STED) microscopy, we show that
TRIOBP-1 interacts directly with hERG and colocalizes with hERG
in cardiomyocytes. TRIOBP-1 bidirectionally regulates hERG
protein levels in HEK293 cells and, when overexpressed in
cardiomyocytes, alters IKr magnitude and cell excitability.Received 12 July 2017; Accepted 12 February 2018
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RESULTS
TRIOBP-1 interacts directly with hERG
To identify hERG-interacting proteins, we conducted a yeast two-
hybrid screen of 2.2×106 clones in a human cardiac cDNA library
using a construct encoding the hERG C-terminal region as bait
(residues 669–1159, Fig. 1A). Positive interactions were scored as
those exhibiting growth with histidine drop-out selection and the
more stringent adenine drop-out selection (Table 1) (James et al.,
1996; Roti Roti et al., 2002). Positive colonies were blue on plates
containing X-gal, indicating induced expression of the β-
galactosidase reporter. All markers reflect complementation of the
activation and binding domains of Gal4, mediated by the interaction
of the bait and prey fusion proteins, that is, hERG and the associated
binding protein. Of five different genes identified, two independent
clones encoded the protein TRIOBP-1, also known as Trio-associated
repeat on actin (Tara) (Seipel et al., 2001) (Table 1). The two-hybrid
isolates encoded TRIOBP-1 (amino acids 361–593), comprising the
C-terminal end of the protein (Fig. 1A). TRIOBP-1 did not interact
with the control C-terminus of Shaker B, a distantly-related
Drosophila K+ channel (Fig. 1A; Table 1) (Papazian et al., 1987).
Because two-hybrid interactions occur between two proteins post-
translationally targeted to the yeast nucleus where spurious
interactions between the bait and other proteins are unlikely, these
data demonstrate a direct and potentially specific interaction between
the hERG C-terminus and the TRIOBP-1 coiled-coil domain.
To corroborate our findings from the yeast two-hybrid
experiments, we tested for association between TRIOBP-1 and
isolated domains of hERG by using a FRET two-hybrid interaction
assay in HEK293 cells (Gianulis et al., 2013; Wesdorp et al., 2017).
We co-expressed the C-terminal region of hERG fused to CFP or to
Citrine with TRIOBP-1 fused to Citrine or to CFP, respectively, and
performed fluorescence imaging and spectral analysis (Fig. 1B–D).
The C-terminal region of hERG fused to Citrine exhibited FRET
with TRIOBP-1 fused to CFP (Fig. 1B,D), and the C-terminal
region of hERG fused to CFP showed FRET with TRIOBP-1 fused
to Citrine (Fig. 1D). We report a value proportional to FRET
efficiency as RatioA−RatioA0 (Eqns 1 and 2, see Materials and
Methods) where a value >0 indicates FRET and an association of the
fluorophores to within ∼80 Å (Fig. 1D) (Gianulis et al., 2013). In
contrast, co-expression of the hERG 1a N-terminal PAS domain
(amino acids 1–135) fused to CFP with TRIOBP-1 fused to Citrine
did not show FRET, with a RatioA−RatioA0 value that was not
significantly different from that in a negative control co-expressing
the PAS domain–CFP and a calmodulin mutant that does not bind
Fig. 1. hERG and TRIOBP-1 associate in
a FRET two hybrid interaction assay.
(A) hERG (top) and TRIOBP-1 (bottom)
structural schematics. The relative
locations of the transmembrane (S1–S6)
and the cyclic nucleotide-binding
homology (CNBHD) domains of hERG as
well as the pleckstrin homology (PH) and
coiled-coil domains of TRIOBP-1 are
shown. The fragments used in the yeast
two-hybrid screen are depicted as black
bars. Key hERG fragments used for FRET
are depicted as blue bars. The regions
used for generating the three anti-TRIOBP-
1 antibodies used in this study are shown
as magenta bars. (B,C) Representative
emission spectra from HEK293 cells
expressing either (B) TRIOBP-1–CFP plus
hERG (666-1159)–Citrine or (C) hERG (1–
135)–CFP plus TRIOBP-1–Citrine, which
acts as a negative control. The total
emission spectrum from excitation at
436 nm is shown in dark blue. The
extracted spectrum (red trace) is the CFP
emission (cyan trace) subtracted from the
total emission spectrum (dark blue) and
contains the Citrine emission with
excitation at 436 nm. The green trace is the
Citrine emission with 500 nm excitation.
RatioA is a ratio of the values of the red to
green trace. RatioA0 is the red:green ratio
from the Citrine-only control. (D) Bar graph
showing RatioA−RatioA0 for CaM1234–
YFP+hERG 1a (1-135)–CFP (the negative
control), hERG 1a (1–135)–CFP plus
CNBHD (666-872)–Citrine (positive
control), TRIOBP-1–CFP plus hERG 1a
(666-1159)–Citrine, and hERG 1a (666-
1159)–CFP plus TRIOBP-1–Citrine. Data
are mean±s.e.m. (n=7–19). *P<0.05
compared to negative control (two-tailed
t-test).
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Ca2+ (CaM1234) (Fig. 1C,D). ACFP-tagged PAS co-expressed with
a Citrine-tagged hERG cyclic nucleotide-binding homology
domain (CNBHD) served as a positive FRET control (Fig. 1D)
(Gianulis et al., 2013). Taken together with the findings from
yeast-two hybrid studies, the FRET results show that the hERG
C-terminal domain associates with TRIOBP-1.
TRIOBP-1 and ERG protein associate in native myocardium
We used three criteria to identify TRIOBP-1 on western blots of
lysate from native tissue: (1) the signal migrates according to the
size predicted from the primary sequence; (2) the signal is identified
by two or more antibodies generated against different epitopes; and
(3) corresponding signals are present in multiple species. We used
three antibodies for these studies: one monoclonal, generated
against a GST-fusion protein including TRIOBP-1 residues 13–385
(anti-TRIOBP-1M) (Seipel et al., 2001), a custom rabbit polyclonal
anti-peptide antibody raised against a TRIOBP-1 fragment within
the coiled-coil sequence (anti-TRIOBP-1R), and a commercially
available monoclonal anti-TRIOBP-1 antibody (anti-TRIOBP-1SC)
(Fig. 1A) (see Materials and Methods).
We probed for TRIOBP-1 in total rat heart, canine ventricle and
non-diseased human donor ventricles. In lysates from rat (n=7) and
canine (n=9) hearts, western blots probed with either TRIOBP-1M or
TRIOBP-1R antibodies revealed a band of 65–68 kDa, corresponding
to the molecular mass predicted from the cDNA (Seipel et al., 2001).
Fig. 2A shows western blots obtained from rat, canine and human
heart lysates probed with the TRIOBP-1M antibody. While additional
bands were detected (Tables S1 and S2), only the 65–68 kDa band
was detected by both TRIOBP-1M and TRIOBP-1R antibodies. In
non-diseased human donor ventricular lysates, western blotting
revealed a signal at 70–73 kDa (n=10) (Fig. 2A, right). Although
additional bands were detected (Table S3), the 70–73 kDa band was
the only band that was present in all ten hearts and corresponds to the
predicted 74 kDa size of human TRIOBP-1 (Bradshaw et al., 2014;
Seipel et al., 2001). These results support the conclusion that
TRIOBP-1 is expressed in canine, rat and human cardiac tissue.
We next used co-immunoprecipitation (co-IP) to determine
whether hERG and TRIOBP-1 associate in HEK293 cells.
HEK293 cells stably expressing hERG 1a were transfected with
TRIOBP-1 to enhance the TRIOBP-1 signal (Fig. S1). Proteins were
immunoprecipitated from cell lysates using the anti-TRIOBP-1R
antibody and immunoblotted for hERG (Fig. 2B,C; Fig. S1). These
blots showedbothmature and immature hERG1a in protein fractions
immunoprecipitated by the TRIOBP-1R antibody (Fig. 2C).
Table 1. Summary of the yeast two-hybrid assay results
Bait Prey
Bait selection
−Trp, −Leu
Bait+prey 1
–Trp, −Leu, −His
Bait+prey 2
−Trp, −Leu, −Ade
Bait+prey reporter
−Trp, −Leu + X-gal
hERG C-term TRIOBP-1 C-term + + + Blue
hERG C-term TRIOBP-1 + + + Blue
Shaker C-term TRIOBP-1 C-term + – – White
hERG C-term None + – – White
hERG C-term Empty Vector + – – White
hERG C-term pSLAM5′-1 + – – White
TRIOBP-1 C-term hERG C-term + + + Blue
TRIOBP-1 hERG C-term + + + Blue
TRIOBP-1 C-term Shaker C-term + – – White
+, growth on plate; −, no growth.
Fig. 2. ERG and TRIOBP-1 co-immunoprecipitate.
(A) Identification of TRIOBP-1 signal (*) on western blots
from freshly isolated canine (left), rat (middle) and human
(right) cardiac tissue. (B) Western blot of whole-cell lysates
of TRIOBP-1-transfected HEK293 cells stably expressing
hERG 1a (left) and freshly isolated rat left ventricular (Rat
LV) tissue (right). (C) hERG (HEK cells) and rERG (rat
tissue) as in B co-immunoprecipitated with a rabbit anti-
TRIOBP-1 antibody and immunoblotted with rabbit
anti-hERG-KA antibody (anti-1a). Both hERG and rERG
co-immunoprecipitated with TRIOBP-1 in three out of three
experiments. The signals observed were not apparent in
bead-only or IgG controls (right).
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We repeated these experiments in native rat heart, where we
demonstrated with co-IP the association of rat ERG and TRIOBP-1.
The membrane fraction isolated from rat ventricles revealed a 65–
68 kDa band detected by the anti-TRIOBP-1 antibody that
associated with ERG that generated bands at ∼130 and ∼150 kDa
(Fig. 2C) (Pond et al., 2000) but is not detected in bead-only or IgG
controls. The co-IP of ERG with TRIOBP-1 in both HEK293 cells
and in native tissues confirms the association of TRIOBP-1 and
ERG protein as predicted by the two-hybrid and FRET studies.
TRIOBP-1 and ERG colocalize in cardiomyocytes
We performed immunocytochemistry in rat cardiomyocytes to
define the distribution of TRIOBP-1 in relation to ERG and the
sarcomeric structure of a native cell (Fig. 3). The predominant
TRIOBP-1 signal colocalized with myosin binding protein C
(MyBP-C; also known as MYBPC3), a thick filament-associated
protein (Harris et al., 2002) (Fig. 3A,C). The secondary TRIOBP-1
signal overlapped with ERG staining between MyBP-C doublets
and corresponds to the Z-line and T-tubule distribution previously
described for ERG (Fig. 3B,D,E) (Jones et al., 2004). Thus,
TRIOBP-1 appears to colocalize with ERG in the T-tubules along
with a more prominent distribution in a separate compartment
occupied by MyBP-C.
TRIOBP-1 overexpression reduces hERG protein levels in
heterologous systems
To characterize the consequences of the interaction between
TRIOBP-1 and hERG, we first determined whether changes in
TRIOBP-1 levels altered hERG trafficking or protein levels. We
measured hERG protein stably expressed in HEK293 cells bymeans
of a western blot analysis, and monitored its maturation from the
immature, endoplasmic reticulum (ER)-associated glycoform to the
mature, Golgi-glycosylated form destined for the plasma membrane
(Zhou et al., 1998). We measured the amount of mature and
immature glycoforms normalized to total hERG protein when co-
expressed with CFP (control) or TRIOBP-1–CFP.We found that the
TRIOBP-1 reduced the proportion of mature hERG by a small but
statistically significant margin (Fig. 4A,B). The total protein showed
a larger reduction of ∼20% (Fig. 4C). To more directly assess the
relative levels of hERG at the plasma membrane, we used a surface
biotinylation assay (see Materials and Methods). Surface protein
labeled with biotin showed a more robust reduction of hERG upon
TRIOBP-1 overexpression, to ∼50% of control (Fig. 4D,E).
TRIOBP-1 overexpression reduces hERG current in
heterologous systems
To determine whether changes in protein levels due to TRIOBP-1
overexpression corresponded to functional changes in hERG
current, we measured membrane currents at room temperature
using whole-cell patch-clamp of HEK293 cells stably expressing
hERG 1a and transfected with cDNA encoding either CFP (control)
or TRIOBP-1 with a CFP C-terminal tag (TRIOBP-1–CFP)
(Fig. 5A–C). Compared to what was seen with CFP controls,
TRIOBP-1–CFP-transfected cells displayed a significant decrease
in hERG steady-state and maximal tail current amplitude. hERG
rectification and voltage dependence of activation were unaffected
(Fig. 5B,C). The reduction in membrane currents corresponds
quantitatively to the reduction observed in surface membrane
protein as described above (cf. Fig. 4D,E).
We conducted parallel experiments using two-electrode voltage
clamp in Xenopus oocytes injected with cRNA encoding hERG 1a
alone or co-injected with TRIOBP-1 cRNA (Fig. 5D–I). Similar to
the findings in transfected HEK293 cells, co-expression of hERG 1a
with TRIOBP-1 reduced both the steady-state and maximal tail
current amplitudes by ∼50%, without a significant effect on the
voltage dependence of activation (Fig. 5D–F). In contrast, currents
produced by hERG 1a subunits lacking the C-terminal region
distal to the CNBHD (hERG Δ882–1159) were unaffected by
TRIOBP-1 coexpression, indicating that the reduction in hERG 1a
current upon TRIOBP-1 overexpression requires the presence of the
C-terminal region distal to the CNBHD domain. Importantly,
this observation also demonstrates that suppression of wild-type
hERG 1a currents is not a consequence of TRIOBP-1 competing
for the translational machinery (Fig. 5G–I). Therefore, exogenous
TRIOBP-1 regulates hERG current magnitude through an
interaction with the hERG C-terminus comprising the TRIOBP-1-
binding region.
TRIOBP-1 overexpression in human cardiomyocytes
reduces IKr
To determine whether native IKr is affected by TRIOBP-1
overexpression, we performed patch-clamp electrophysiology
experiments in cardiomyocytes derived from human induced
pluripotent stem cells (iPSC-CMs) (Harley et al., 2016; Jones
et al., 2014, 2016; Ma et al., 2011). IKr, measured as an E-4031-
sensitive current (see Materials and Methods), was markedly
reduced by TRIOBP-1 overexpression (Fig. 6A,B). Only cells with
a robust ICa, used as an indicator of cell viability, were included for
analysis. TRIOBP-1 transfection reduced the maximum IKr tail
current density by ∼70% relative to CFP controls (Fig. 6B; Fig. S2,
Table S4). TRIOBP-1 did not affect the voltage dependence of IKr
(Fig. 6B; Table S4). The effects of TRIOBP-1 overexpression on IKr
in cardiomyocytes are consistent with the effects on hERG 1a
heterologously expressed in HEK293 cells.
TRIOBP-1 overexpression in human cardiomyocytes alters
action potential behavior
Predicting that reduced IKr would prolong the action potential (AP)
duration (APD), we compared the APD in Kir2.1 (KCNJ2)-
transduced cardiomyocytes transfected with TRIOBP-1–CFP
versus CFP alone (see Materials and Methods). Unexpectedly,
despite a trend toward APD prolongation, this difference was not
statistically significant (Fig. 6C–F; P=0.08, n=11–14). However,
we noted a significant increase in AP triangulation, a measure of
phase III repolarization and marker for pro-arrhythmia (Hondeghem
et al., 2001) (Fig. 6D,G; P=0.03). Furthermore, in a subset of
cardiomyocytes (7 of 20 cells), exogenous TRIOBP-1 conferred
depolarization block resulting from a resting membrane potential of
−8.2±1.9 mV, presumably the result of reduced IKr in the TRIOBP-
1-transfected cells (Fig. 6E,H). In contrast, all control iPSC-CMs
displayed a resting membrane potential near −80 mV (Fig. 6C,H)
(n=17). To confirm that the depolarized TRIOBP-1 cells were
in fact cardiomyocytes, as opposed to non-excitable fibroblasts,
we tested for electrical excitability by hyperpolarizing the cell
prior to a depolarizing test pulse (Fig. S3). Quiescent cells were
included for analysis only if they displayed an AP following
manual hyperpolarization. These data indicate that exogenous
TRIOBP-1 enhances AP triangulation and causes depolarization
block in cardiomyocytes.
TRIOBP-1 overexpression in human cardiomyocytes also
reduces ICa
The failure of TRIOBP-1 overexpression to cause an increase in
APD despite its effect on IKr, suggests that there is a
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compensatory effect during the AP plateau. Indeed, we observed
that TRIOBP-1 overexpression also significantly reduced ICa
density by 40% (Fig. 6I,J; Fig. S2; Table S4). TRIOBP-1 did not
affect the voltage dependence of ICa activation or inactivation
(Table S4).
Consistent with previous reports that TRIOBP-1 overexpression
increased cell size (Bradshaw et al., 2014; Seipel et al., 2001),
TRIOBP-1–CFP transfection significantly increased cellular
capacitance from 36.3±3.3 pF in CFP-transfected iPSC-CMs to
52.0±3.3 pF in TRIOBP-1–CFP-transfected iPSC-CMs (mean±
Fig. 3. TRIOBP-1 and ERG distribution in native rat cardiomyocytes. (A) Images showing native rat cardiomyocytes immunolabeled for TRIOBP-1 (magenta,
left), MyBP-C (green, middle) and the merged signal (right). (B) Sample images showing native rat cardiomyocytes immunolabeled for TRIOBP-1 (magenta, left),
rERG (green, middle) and the merged signal (right). (C) Linear fluorescence intensity profile depicting the periodic colocalization of TrioBP-1 (magenta) and
MyBP-C (green) from an individual cell. (D) Linear fluorescence intensity profile depicting the periodic colocalization (arrows) of TRIOBP-1 (magenta) and ERG
(green) from an individual cell. (E) 3D rendering of TRIOBP-1 staining. Orange arrows indicate secondary TRIOBP-1 fluorescence that correlates with ERG
fluorescence. Scale bars: 10 μm.
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s.e.m., n=8–12, P=0.004). The magnitude of the effect of
TRIOBP-1 on cell size is inversely proportional to that on ICa
current density. Whether the reduction in ICa density is directly
attributable to an interaction of the channel with TRIOBP-1 or an
indirect effect of increasing membrane area will require further
investigation.
TRIOBP-1 overexpression disrupts hERG protein distribution
in human cardiomyocytes
In an attempt to understand the basis for reduced IKr levels caused
by TRIOBP-1 overexpression, we evaluated the distribution of the
two proteins by performing immunocytochemistry in iPSC-CMs.
Immunostaining against TRIOBP-1 and hERG showed a strong
punctate signal for both proteins when imaged through confocal and
stimulated emission depletion (STED) microscopy (Fig. 7A).
Interestingly, the distribution of both TRIOBP-1 and hERG was
altered following overexpression of TRIOBP-1 via transfection, as
compared to what was seen with GFP vector controls. Both signals
redistributed to intracellular vesicle-like structures (Fig. 7B), even as
the cell size increased. These vesicular aggregates were also visible
in all cells evaluated for AP and current properties, and did not
appear to affect cell viability. Other studies on TRIOBP-1 also show
that aggregates form upon overexpression of TRIOBP-1 without an
effect on viability (Bradshaw et al., 2014, 2017). We conclude that
reduction of IKr current density upon TRIOBP-1 overexpression is
primarily attributable to the co-sequestration of hERG protein in
internal vesicular or vacuolar structures.
To evaluate the effects of reducing TRIOBP-1 expression on
hERG protein levels and hERG and IKr current magnitude, we
conducted RNAi experiments. We used two commercially available
short hairpin (sh)RNA that reduced TRIOBP-1 expression by 50–
60% and observed a two-fold upregulation of hERG protein
expressed in HEK293 cells, the opposite effect to what was seen
with TRIOBP-1 overexpression (Fig. S4; cf. Fig. 4). Despite the
upregulation of hERG protein levels, TRIOBP-1 knockdown
reduced hERG currents in HEK293 cells. TRIOBP-1 knockdown
did not significantly affect IKr current or AP properties in
cardiomyocytes (Fig. S5).
Genetic screening
A screen using whole-exome sequencing of 28 unrelated patients
with clinically robust but genetically elusive LQTS was performed
in an effort to uncover potential determinants for pathology in
TRIOBP-1. We identified no ultra-rare non-synonymous variants
(minor allele frequency <0.005%) in TRIOBP-1 in this patient
group.
DISCUSSION
Our study describes a direct ion channel interaction with the actin-
binding protein TRIOBP-1 as determined through yeast and
mammalian FRET two-hybrid assays. The interaction takes place
between the TRIOBP-1 C-terminus and a domain within the hERG
C-terminal region, which extends from the C-linker domain to the C-
terminus and includes the CNBHD.We identified signals onwestern
blots corresponding to TRIOBP-1 in multiple species, and show that
TRIOBP-1 co-immunoprecipitates with ERG from native tissue
lysates. In cardiomyocytes, TRIOBP-1 exhibits a periodic signal that
is coincident with MyBP-C, and a secondary signal corresponding
to the Z-lines where ERG has been previously localized to T-tubules
(Jones et al., 2004). Overexpression of TRIOBP-1 in HEK293 cells
decreased hERG protein levels and current amplitude in HEK293
cells. Current reduction was also demonstrated in Xenopus oocytes,
but not when the distal C-terminal region (TRIOBP-1-binding
region) was deleted, supporting the conclusion that the reduction of
current was attributable to the interaction of TRIOBP-1 and the
hERG C-terminal region and not a competition for the protein
translational machinery. In iPSC-CMs, TRIOBP-1 overexpression
correspondingly reduced native IKr. Although a trend in AP
prolongation was observed, the change did not reach statistical
significance, possibly because of a concomitant reduction in ICa.
However, the coefficient of triangulation, a measure of phase III
repolarization and marker for pro-arrhythmia (Hondeghem et al.,
2001), was significantly increased (by about half ), and many cells
exhibited depolarization block as compared to the controls that
exhibited normal AP parameters and resting potential. The reduction
in IKr corresponded to a vesicular or vacuolar sequestration of hERG
and TRIOBP-1 protein in the iPSC-CMs.
TRIOBP-1 is one of several isoforms encoded by alternative
transcripts and splicing at the TRIOBP locus (Shahin et al., 2006). It
has been shown to directly bind actin in a periodic pattern
corresponding to myosin II in HeLa cells, where its interaction
stabilizes actin in the presence of depolymerization agents (Seipel
et al., 2001; Shahin et al., 2006). None of the signals that we detected
on western blots of heart tissue or HEK293 cells corresponds to the
predicted size of any other TRIOBP isoforms, which supports
previous RT-PCR and northern blot data showing that TRIOBP-1 is
the only isoform expressed in human heart (Seipel et al., 2001;
Shahin et al., 2006).AlthoughTRIOBP isoforms 4 and5 are involved
in bundling actin at the base of the stereocilia in the inner hair cell, the
region associated with this mechanism is not represented in the
TRIOBP-1 isoform (Kitajiri et al., 2010; Riazuddin et al., 2006;
Fig. 4. TRIOBP-1 regulates hERG protein expression in HEK293 cells.
(A) Example western blot of HEK293 cells stably expressing hERG 1a and
transfected with CFP or TRIOBP-1–CFP. Protein disulfide isomerase (PDI) is
shown as a loading control. (B) Quantification of the amount of mature hERG
protein (155 kDa band) divided by total hERG protein (155 kDa plus 135 kDa
bands). (C) Quantification of total hERG protein (155 kDa plus 135 kDa bands)
divided by the loading control (PDI). (D) Representative immunoblot showing
biotinylated hERG protein (top) and unbiotinylated PDI loading controls
(bottom) from HEK293 cells stably expressing hERG 1a and transfected as in
A. (E) Quantification showing that the amount of the biotinylated 155 kDa
hERG protein band is substantially reduced upon TRIOBP-1–CFP expression
as compared to CFP controls. Data are plotted asmean±s.e.m. (n=3).*P<0.05.
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Shahin et al., 2006). Thus, the effects of TRIOBP-1 on the actin
cytoskeleton likely arise from a distinct mechanism.
What is the physiological role of the interaction between
TRIOBP-1 and hERG? Actin and actin-binding proteins, like
TRIOBP-1, have a wide range of effects on ion channels. Ion
channels such as Kv4.2, or Cavβ subunits, are stabilized by a direct
interaction with actin (Petrecca et al., 2000; Stölting et al., 2015),
and cortical actin can serve to restrict movement of channels
to delimited regions (Sadegh et al., 2017). The small-conductance
Ca2+-activated K+ channel SK2 colocalizes with filamin A along the
Z-line (Rafizadeh et al., 2014). Ankyrins localize ion channels via
interactions with the cytoskeleton, and can harbor mutations giving
rise to LQTS (Makara et al., 2014; Mohler et al., 2003). The
physiological role of the interaction between TRIOBP-1 and hERG
remains to be fully elucidated, but in addition to its interaction with
hERG, TRIOBP-1 stabilizes actin polymerization (Seipel et al.,
2001). This independent action may explain why TRIOBP-1
knockdown in HEK293 cells caused a reduction in hERG current
despite a twofold increase in hERG protein: a loss of actin filaments
would interfere with the stabilizing effect of actin at the membrane.
Indeed, a dependence of ERG current levels on the cytoskeleton was
previously observed in GH3/B6 cells where treatment with
cytochalasin D, which inhibits actin polymerization, reduces ERG
currents by 70% (Schledermann et al., 2001). We speculate that
TRIOBP-1 provides a scaffold between the membrane-bound ERG
channel and the actin filaments, linking excitability with membrane
structure and cell motility.
The large reductions in hERG current and IKr at the membrane
when TRIOBP-1 levels are elevated was not fully explained by the
reduction in total protein or a trafficking delay in the ER. Instead,
TRIOBP-1 overexpression in cardiomyocytes results in internal
concentration of hERG in vesicular bodies reminiscent of
autophagic vacuoles, which were also described in HeLa cells
(Seipel et al., 2001). Whether TRIOBP-1 and hERG colocalization
in iPSC-CMs is an artifact of overexpression or a clue to
mechanism, the colocalization of TRIOBP-1 and hERG in these
subcellular structures reinforces the conclusion that the two proteins
interact in cardiomyocytes. Moreover, it is interesting to note that
autophagic vacuoles are abundant in failing human heart tissue, and
vacuole formation is triggered by stress in experimental systems
(Saito et al., 2016). Whether they are deleterious or cardioprotective
is unclear, but if IKr channels are sequestered during the process, the
concomitant current reduction could contribute to arrhythmia risk
associated with heart failure.
The aggregation observed with exogenous TRIOBP-1 expression
mayalso have relevance to other disease processes.Antibodies raised to
aggregates found postmortem in brains of patients with schizophrenia
identified TRIOBP-1 as a major constituent (Bradshaw et al., 2014).
The same study demonstrated that overexpression of TRIOBP-1,
but not TRIOBP-4, triggered similar protein aggregates in
neuroblastoma cells, much like the intracellular compartments we
observed in iPSC-CMs. Interestingly, upregulation of the hERG
isoform KV11.1-3.1 has also been linked to schizophrenia via
Fig. 5. TRIOBP-1 overexpression reduces hERG current in two
heterologous systems. (A) Sample current traces recorded from HEK293
cells stably expressing hERG 1a and transfected with pcDNA-CFP (left) or
TRIOBP-1–CFP (right). (B) Steady-state current plotted as a function of test
potential for hERG 1a plus CFP (squares) and hERG 1a plus TRIOBP-1–CFP
(diamonds). (C) Maximal tail current plotted as a function of pre-pulse potential
for hERG 1a plus CFP (circles) and hERG 1a plus TRIOBP-1–CFP (triangles)
and fitted to a Boltzmann equation (Eqn 3). (D) Sample current traces recorded
from Xenopus oocytes expressing hERG 1a–CFP alone (left) or hERG 1a plus
TRIOBP-1–CFP together (right). (E) Steady-state current plotted as a function
of test potential for hERG 1a (circles) and hERG 1a plus TRIOBP-1–CFP
(triangles). (F) Maximal tail current plotted as a function of pre-pulse potential
for hERG 1a (circles) and hERG 1a plus TRIOBP-1–CFP (triangles) and fitted
to a Boltzmann equation (Eqn 3). (G) Sample current traces recorded from aC-
terminal truncated hERG 1a mutant (hERG Δ882-1159, left) or hERG Δ882-
1159 plus TRIOBP-1–CFP together (right). (H) Steady-state current plotted as
a function of test potential for hERG Δ882-1159 (circles) and hERG Δ882-1159
plus TRIOBP-1 (triangles). (I) Maximal tail current plotted as a function of pre-
pulse potential for hERG Δ882-1159 (circles) and hERG Δ882-1159 plus
TRIOBP-1 (triangles) and fitted to a Boltzmann equation (Eqn 3). Data are
plotted as mean±s.e.m. (n=6–12). *P<0.05 (two-tailed t-test).
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genome-wide association and experimental studies (Apud et al.,
2012; Atalar et al., 2010; Carr et al., 2016; Huffaker et al., 2009);
it would be interesting to know whether association of hERG
with TRIOBP-1 plays a role in schizophrenia pathogenesis at the
cellular level.
We have established an interaction between hERG and TRIOBP-
1 that may be important in cardiac excitability. Future studies will be
required to determine whether the interaction plays a regulatory role
in cardiac excitability or contributes to pathology, particularly in
light of the paradoxical increase in hERG protein and decrease in
hERG current levels when TRIOBP-1 levels are reduced.
Perturbation of the interaction in cardiomyocytes via introduction
of peptides or small-chain variable antibodies through the recording
pipette may yield such insights (Harley et al., 2016). Moreover, the
physiological role of the interaction in iPSC-CMs, which are
considered to be at an embryonic stage (Mummery et al., 2003), may
differ from that in mature cardiomyocytes. Ultimately, the
identification of human disease mutations in TRIOBP-1 through
additional genomic analysis may help resolve the physiological role
of its interaction with hERG and the IKr channel in the heart.
MATERIALS AND METHODS
Yeast two-hybrid screen
Binary interactions were evaluated by using a yeast two-hybrid assay as
previously described (Roti Roti et al., 2002). Briefly, PJ69-4a yeast were
transformed singly or dually with plasmids containing recombinant clones
fused to either the Gal4 activation domain (pACT2) or the Gal4 binding
domain (pAS2-1). Initial transformants were selected on synthetic dropout
Fig. 6. TRIOBP-1 modifies cardiomyocyte electrophysiology. (A) E-4031-
sensitive traces, representing IKr, recorded from iPSC-CMs transfected with
either CFP (top) or TRIOBP-1–CFP (bottom). (B) Maximal tail IKr recorded from
iPSC-CMs transfected with either CFP (closed squares) or TRIOBP-1–CFP
(open squares), plotted as a function of pre-pulse potential, and fitted to a
Boltzmann function (Eqn 3). (C–E) Sample AP traces from iPSC-CMs
transfected with CFP (C) or TRIOBP-1–CFP (D,E). TRIOBP-1–CFP
transfection triggered two AP morphologies, excitable cells with triangulated
AP morphologies (D) and depolarized cells (E). (F) Summary data showing
APD90 recorded from iPSC-CMs transfected with CFP or TRIOBP-1–CFP.
(G) Summary data showing APD triangulation (Eqn 4) recorded from iPSC-CMs
transfected with CFP or TRIOBP-1–CFP. (H) Resting potential recorded from
CFP-transfected iPSC-CMs and the two morphologies of TRIOBP-1–CFP-
transfected iPSC-CMs (cf. D,E). (I) ICa recorded from iPSC-CMs transfectedwith
either CFP (top) or TRIOBP-1–CFP (bottom). (J) GCa recorded from iPSC-CMs
transfected with either CFP (closed squares) or TRIOBP-1–CFP (open
squares), plotted as a function of test potential, and fitted to aBoltzmann function
(Eqn 3). Data are plotted as mean±s.e.m. (n=7–17); see Results section for
details on sample size. *P<0.05 compared to CFP (two-tailed t-test).
Fig. 7. TRIOBP-1 overexpression disrupts hERG protein distribution.
(A) Confocal (top row) and super resolution stimulated emission depletion
(STED) images (bottom row, from the same cell) showing endogenous
TRIOBP-1 (magenta) and hERG (green) fluorescence in human iPSC-CMs.
(B) Confocal (top row) and STED images (bottom row, from the same cell)
showing TRIOBP-1 (magenta) and hERG (green) fluorescence in iPSC-CMs
following TRIOBP-1–CFP overexpression.
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plates (SD) lacking leucine (–Leu), tryptophan (−Trp), or both, as
appropriate for the transformed vector(s). Colonies were replica-plated to
selection media additionally lacking adenine or histidine; growth on these
plates reports a protein–protein interaction. Yeast colonies were also replica-
plated to selection media containing X-Gal, where a blue colony phenotype
indicates a positive protein–protein interaction. Representative colonies
from each set of transformants were restreaked onto SD –Leu −Trp plates
and replica plated to interaction selection plates (−Ade, −His, +X-Gal).
Cell membrane protein preparations
HEK293 cells were maintained and transfected in 60 mm tissue culture
dishes (Corning Inc., Corning, NY). Cells werewashed with ice-cold PBS at
48 h post transfection and resuspended in lysis buffer [150 mM NaCl,
25 mM Tris-HCl, 5 mM glucose, 20 mM NaEDTA, 10 mM NaEGTA
10 mM, 1% Triton X-100, 50 μg/ml 1,10 phenanthroline, 0.7 μg/ml
pepstatin A, 1.56 μg/ml benzamidine, and 1× Complete Minitab (Roche
Applied Science)]. After sonicating twice (amplitude 20 for 10 s on ice),
samples were rotated for 20 min at 4°C, centrifuged at 10,000 g at 4°C, and
supernatants analyzed. Protein concentration was determined with a
modified Bradford assay (DC Protein Assay, Bio-Rad).
Sprague-Dawley rat ventricles were excised from anesthetized adult males
after intraperitoneal injection of sodium pentobarbital (100 mg/kg body
weight). All animal experiments were performed according to procedures
approved by the University of Wisconsin Institutional Animal Care and Use
Committee. Ventricular tissue was homogenized in tissue homogenization
solution [25 mM Tris-HCl, pH 7.4, 10 mM NaEGTA, 20 mM NaEDTA,
50 μg/ml 1,10 phenanthroline, 0.7 μg/ml pepstatin A, 1.56 μg/ml
benzamidine, and 1× Complete Minitab (Roche Applied Science)]. After
homogenization with a Tissue Tearor (2×10 s bursts), lysates were sonicated
twice for 10 s on ice, and then centrifuged at 1000 g for 10 min at 4°C. The
supernatantwasdecanted and thepellet resuspended in tissuehomogenization
solution and the homogenization, sonication and centrifugation repeated.
Supernatants were combined and centrifuged at 40,000 g for 30 min at 4°C,
and pellets resuspended inRIPA buffer [150 mMNaCl, 50 mMTris-HCl, pH
7.4, 1 mM NaEDTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1%
sodiumdodecyl sulfate, 50 μg/ml 1,10 phenanthroline, 0.7 μg/ml pepstatinA,
1.56 μg/ml benzamidine, and 1× Complete Minitab (Roche Applied
Science)], and incubated at 4°C with rotation for 2–3 h, and were then
centrifuged at 10,000 g for 10 min at 4°C to remove any insoluble material.
The supernatants were retained for analysis. Integral membrane proteins from
canine ventricular tissue (a gift from Dr Cynthia Carnes, Ohio State
University, OH) were isolated as described for rat tissue.
Human cardiac tissue samples from non-diseased human hearts deemed
unusable for transplantation were frozen immediately in liquid nitrogen until
further processing. Before explantation of the heart, organ donors did not
receive medication other than dobutamine, furosemide and plasma
expanders. The investigations conformed to the principles of the
Declaration of Helsinki, and samples were obtained with informed
consent. The experimental protocols were approved by the Scientific and
Research Ethical Committee of the Medical Scientific Board at the
Hungarian Ministry of Health (ETT-TUKEB: 4991-0/2010-1018EKU).
For crudemembrane preparations, ventricular tissuewas broken into small
pieces in liquid nitrogen and homogenized in Tris-EDTA buffer [5 mMTris-
HCl pH 7.4, 2 mM EDTA, 50 μg/ml 1,10 phenanthroline, 0.7 μg/ml
pepstatin A, 1.56 μg/ml benzamidine, and 1× Complete Minitab (Roche
Applied Science)] to a final concentration of 50 mg/ml Tris-EDTA. Tissue
was homogenized with a Tissue Tearor, and centrifuged at 40,000 g for
30 min at 4°C. The resulting pellet was solubilized in solubilization buffer
[50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, 1% sodium
deoxycholate, 0.1%SDS, 50 μg/ml 1,10 phenanthroline, 0.7 μg/ml pepstatin
A, 1.56 μg/ml benzamidine, and 1× Complete Minitab (Roche Applied
Science)] to a final concentration of 0.1 g tissue/1 ml solubilization buffer,
and incubated for 2 h at 4°C with rotation. Solubilized proteins were then
centrifuged at 4000 g for 10 min at 4°C, and the supernatant was analyzed.
Immunoprecipitation
HEK293 whole cell lysates (250 μg) were precleared with 30 μl protein
A–Sepharose beads for 1 h at 4°C. After centrifugation (1 min at 10,000 g
and4°C) to remove beads, 0.25 μg rabbit anti-hERG-KAR2antibody (custom
made) was added to the supernatant and incubated with rotation for ∼16 h at
4°C. Protein A–Sepharose beads were then added and incubated for an
additional 2 h. Immunoprecipitates were washed three times in 0.5 ml lysis
buffer, and eluted into30 μl Laemmeli sample buffer (LSB) (25 mMTris-HCl,
pH 6.8, 2% sodium dodecysulfate, 10% glycerol, 0.2 M DL-dithiothreitol).
Integral membrane proteins isolated from rat three rat ventricles were
precleared with 50 μl protein G–Sepharose beads for 1 h. Beads were
removed and 15 μl mouse anti-hERG antibody (Axxora) was added to the
supernatant and incubated for ∼16 h at 4°C with rotation. After incubation
with 35 μl protein G–Sepharose beads for 2 h, beads were washed three
times with 250 μl buffer [150 mM NaCl, 50 mM Tris-HCl pH 7.4, 1 mM
NaEDTA, 0.1% Triton X-100, 50 μg/ml 1,10 phenanthroline, 0.7 μg/ml
pepstatin A, 1.56 μg/ml benzamidine, and 1× Complete Minitab (Roche
Applied Science)]. Samples were eluted in 30 μl Laemmeli sample buffer.
Western blots
Whole-cell lysates and integralmembraneproteinpreparationswere separated
by 7.5% SDS-PAGE, and transferred onto polyvinylidene difluoride
membranes or nitrocellulose membranes. Membranes were blocked and
then probed with a 1:5000 dilution of rabbit anti-hERG KA (ALX-215049-
R100, ENZO), 1:500 dilution of rabbit anti-TRIOBP-1r (ab151320, Abcam).
Membranes were washed and then incubated with 1:10,000 dilutions of
secondary Ab Alexa Fluor 647 goat anti-rabbit IgG 21245 or secondary Ab
Alexa Fluor 488 donkey anti-mouse IgG 21202 (Life Technologies) for 1 h,
and imaged using a Chelidon-MP Imaging System (Bio-Rad).
Biotinylation assay
At ∼48 h post-transfection, cells were washed twice with ice-cold PBS and
then treated with 1 mg/ml of EZ-link Sulfo-NHS-SS-biotin (Pierce) dissolved
in PBS for 30 min at 4°C. The unreacted biotin was quenched following an
incubation with 50 mM Tris-HCl (pH 7.5) for 20 min at 4°C. Cells were
washed three times with ice-cold PBS. Following cell lysis, biotinylated
proteins were collected by incubating the cell lysates with neutravidin-coated
agarose beads (Pierce) in PBS buffer containing 0.1% SDS for 2 h at 4°C.
Biotin-bound beads were then washed five times with PBS plus 0.1% SDS.
Biotinylated proteins were eluted from the beads in 2×LSB+β-
mercaptoethanol (Bio-Rad) at room temperature for 30 min. Eluted proteins
were resolved by 7.5% SDS-PAGE followed by western blot analysis.
TRIOBP-1 knockdown
HEK293 cells stably expressing hERG1a or iPSC-CMs were transfected
with 1 µg/ml DNA encoding either a scrambled shRNA control or one of
two shRNAvectors targeting TRIOBP-1 (catalog nos HSH001235-31-CU6
and HSH001235-32-CU6; GeneCopoeia). mRNA, protein levels and
currents were assessed at 48 h post transfection.
FRET two-hybrid assay
The FRET two-hybrid assay was performed as described previously
(Gianulis et al., 2013). HEK293 cells were plated on 35-mm poly-D-lysine-
coated glass-bottom dishes (MatTek) and transiently transfected with
Citrine-tagged or CFP-tagged hERG cDNA constructs and CFP or Citrine-
tagged TRIOBP-1. At ∼24–48 h after transfection, FRET measurements
were taken using an inverted epifluorescence microscope (TE2000-U;
Eclipse; Nikon). Fluorescence emission and spectroscopic measurements
were taken using a spectrograph (SpectraPro 2150i; Acton Research
Corporation) and a camera (CCD97; Roper Scientific). Fluorescence
imaging and analysis were performed with Metamorph software (version
6.3r7; Universal Imaging). FRET analysis was performed by measuring the
fluorescent emission of the acceptor following excitation of the donor where
a RatioA–RatioA0 value greater than 0.0 indicates FRET, and where:
Ratio A ¼ F436
F500
¼ F436FRET
F500
 
þ F436direct
F500
 
; ð1Þ
Ratio A0 ¼ F436directF500 ; ð2Þ
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where F436 is fluorescence at 436 nm and F500 fluorescence at 500 nm.
F436direct and F500 are measured in separate control experiments where
hERG (666–1159)–Citrine fluorescence emission is measured alone
following excitation from a 436 nm and 500 nm light, respectively.
Electrophysiology
Oocytes
Oocytes isolated from female Xenopus laevis frogs were purchased from
Ecocyte Bioscience (for University of Maryland site experiments) and
Nasco (for University of Wisconsin experiments). hERG constructs were
cloned into a pGH19 vector and TRIOBP-1 was cloned into pcDNA3-
mycB/his (Invitrogen). cRNAwas transcribed in vitro using a mMESSAGE
mMACHINE T7 kit (Invitrogen). Purified cRNA was quantified and
injected using a Nanoinject II oocyte injector (Drummond). Oocytes were
injected with hERG or a 1:3 molar ratio of cRNA (50 nl) encoding hERG
and TRIOBP-1, respectively, and incubated at 18°C. At 48 h post injection,
two-electrode voltage-clamp experiments were completed at room
temperature in bath solution containing (in mM): 5 KCl, 93 NaCl, 1
MgCl2, 1.8 CaCl2 and 5 HEPES, and titrated to pH 7.4 using NaOH.
Pipettes were filled with 3 M KCl. From a holding potential of −80 mV,
channels were activated by a series of test potentials from −100 to +60 mV
in 10 mV increments, followed by a repolarization pulse to −60 mV. Data
were recorded using Patchmaster software (HEKA) and analyzed using Igor
Pro software (Wavemetrics) at the University of Maryland. Data were
recorded using pClamp software (Molecular Dynamics) and analyzed with
Origin at the University of Wisconsin site.
HEK293 cells
Cells stably expressing hERG (hERG-HEK293 cells) were cultured in
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10%
fetal bovine serum, 1% L-glutamine, 1% penicillin and 1% streptomycin
and grown at 37°C with 5% CO2. HEK293 cells were plated on 35-mm cell
culture dishes and transfected with 1 µg TRIOPBP-1 cDNA. After 24–48 h,
membrane currents were measured using whole-cell patch-clamp at room
temperature by using an EPC10 patch-clamp amplifier and PatchMaster v
2.0 (HEKA). The pipette solution contained (mM): 130 KCl, 1 MgCl2, 5
EGTA, 5 MgATP and 10 HEPES, titrated to pH 7.2 with KOH. The bath
solution contained (mM): 137 NaCl, 4 KCl, 1.8 CaCl2, 1 MgCl2, 10
glucose, 5 tetraethylammonium and 10 HEPES, titrated to pH 7.4 with
NaOH. Ion currents were measured from a holding potential of −80 mV,
with a series of test potentials from −80 mV to +60 mV in 10 mV
increments, followed by a repolarization pulse to−50 mV. All recorded data
was analyzed using the IgorPro Software (version 5.03; WaveMetrics).
hiPSC-CMs
Human iPSC-CMs (iCell® Cardiomyocytes, Cellular Dynamics
International) were plated and stored in 12-well dishes as per the
manufacturer’s instructions. iPSC-CMs were transfected with 1.5 µg/ml
TRIOBP-1–CFP or CFP via 1.25 µl/ml Lipofectamine 2000. For AP
recordings, iPSC-CMs were transformed with 1 µl/ml of adenoviral lysate.
Adenoviral DNA encoded Kir2.1 in frame with GFP, as described
previously (Jones et al., 2014; Vaidyanathan et al., 2016).
iPSC-CM recordings were conducted at 5–30 days post plating. All iPSC-
CM recordings were completed 48–96 h post transfection at 36±1°C using
whole-cell patch-clamp as described previously (Jones et al., 2016). We
only recorded from cells that displayed GFP fluorescence, which
corresponds to successful Kir2.1 transduction. All recordings were made
using an Axon 200A amplifier and Clampex (Molecular Devices). Data
were sampled at 10 kHz and low-pass filtered at 1 kHz. Cells were perfused
with extracellular solution containing (in mM): 150 NaCl, 5.4 KCl, 1.8
CaCl2, 1 MgCl2, 15 glucose, 10 HEPES, 1 Na-pyruvate, and titrated to pH
7.4 using NaOH. Recording pipettes had resistances of 2-4.5 MΩ when
backfilled with intracellular solution containing (in mM): 5 NaCl, 150 KCl,
2 CaCl2, 5 EGTA, 10 HEPES, 5 MgATP, and titrated to pH 7.2 using KOH.
Intracellular solution aliquots were kept frozen until the day of recording.
During recording, the intracellular solution was kept on ice and discarded
2–3 h after thawing.
IKr and ICa were measured using the same protocol and recorded
simultaneously in the same cell. Voltage protocols were completed before
and after bath perfusion of 2 µM E-4031, an IKr-specific blocker. The
difference in current was taken to represent IKr (Ma et al., 2011; Sanguinetti
and Jurkiewicz, 1990). ICa was measured following bath perfusion of the
2 µM E-4031. iPSC-CMs were stepped from a −50 mV holding potential to
inactivate voltage-gated Na+ currents to a 3-s pre-pulse between −50 and
+30 mV in 10 mV increments. ICa was measured as the peak current
observed in the presence of 2 µM E-4031 during the first 200 ms of the
pre-pulse. Steady-state IKr was measured as the 5 ms mean at the end of the
pre-pulse. Maximal tail IKr was measured at the beginning of a step to
−40 mV following the pre-pulse. Leak subtraction was performed off-line
based on current observed at −40 mV prior to IKr or ICa channel activation.
To describe the voltage dependence of IKr and ICa activation, maximal tail
IKr or peak ICa was normalized to cellular capacitance, plotted as a function
of pre-pulse potential, and fitted to the following Boltzmann equation:
y ¼ A1  A2
1þ eððV  V0ÞdxÞ
 
þ A2; ð3Þ
where A1 and A2 represent the maximum and minimums of the fit,
respectively, V is the membrane potential, V0 is the midpoint and dx is the
slope. We recorded iPSC-CM APs using a whole-cell current-clamp as
described previously (Harley et al., 2016). iPSC-CMs were paced at 1 Hz
using a 5 ms 300–1000 pA stimulus. AP triangulation was calculated as the
ratio of phase three (APD80–APD70) divided by phase two (APD40–APD30).
Subscripts indicate the percentage repolarization.
Triangulation ¼ APD80  APD70
APD40  APD30 : ð4Þ
Immunocytochemistry
Native cardiomyocytes
Experiments were performed as previously described (Jones et al., 2004)
and in accordance with guidelines set by the University of Wisconsin
Institutional Animal Care and Use Committee. Briefly, isolated rat myocytes
were fixed in 2% paraformaldehyde and permeabilized with 0.5% Triton X-
100 for 10 min at room temperature. Myocytes were pre-blocked in PBS, pH
7.4, with 0.1% Tween-20, 5% bovine serum albumin (BSA) for 2 h at 4°C,
then incubated in diluted primary antibody overnight at 4°C with constant
rotation. Antibodies were diluted in PBS, pH 7.4, 0.1%Tween-20, 5%BSA:
mouse anti-TRIOBP-1m at 1:500 (gift fromMichel Streuli), goat anti-hERG
1a N-20 at 1:10 (sc-15966, Santa Cruz Biotechnology), rabbit anti-
TRIOBP-1r at 1:500 (custom made), and rabbit anti-MyBP-C at 1:500
(Harris et al., 2002). Myocytes were washed three times for 1 h in PBS, pH
7.4, with 0.1% Tween-20. Cells were then incubated in secondary antibody
(Alexa Fluor 488-conjugated goat anti-rabbit-IgG and Alexa Fluor 594-
conjugated goat anti-mouse-IgG) diluted in PBS, pH 7.4, 0.1% Tween-20,
5% BSA, 10% serum for 2 h at room temperature with rotation; all Alexa
Fluor-conjugated (Invitrogen-Molecular Probes) were diluted 1:1000 in
antibody dilutant. Samples were washed briefly three times, then twice
for 1 h at 4°C in PBS with 0.1% Tween-20, pH 7.4. Myocytes were
viewed on a Bio-Rad MRC 1024 laser scanning confocal microscope, or
Zeiss Axiovert 200 microscope with a 63× objective using optical
sectioning as described (Jones et al., 2004; Roti Roti et al., 2002).
hiPSC-CMs
Immunocytochemistry was completed as previously described (Jones et al.,
2004). Cells were incubated in blocking solution containing 1:200 dilutions
of primary antibodies targeting hERG (Roti Roti et al., 2002) and 1:100
TRIOBP-1SC (sc-81128, Santa Cruz Biotechnology). Cells were washed
and then incubated with blocking solution containing 1:1000 dilutions of
secondary antibodies [Alexa Fluor 555-conjugated goat anti-mouse IgG (H
+L) A-21422 for TRIOBP-1 and Alexa Fluor® 647-conjugated goat anti-
rabbit IgG A-21245 (Life Technologies) for hERG]. Cells were imaged at
the University of Wisconsin-Madison Optical Imaging Core using a Leica
SP8 confocal microscope. Stimulated emission depletion of Alexa Fluor®
555 and Alexa Fluor® 647 was completed using a 660 nm and 775 nm laser
line, respectively. All cell lines are routinely screened for contamination.
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Genetic screening
Twenty-eight unrelated patients with clinically robust but genetically elusive
LQTS were referred to the Windland Smith Rice Sudden Death Genomics
Laboratory at Mayo Clinic, Rochester, Minnesota, for research-based
genetic testing. All LQTS patients signed a Mayo Clinic IRB-approved
written consent form prior to genetic analysis. Comprehensive mutational
analysis of all 21 coding region exons of the TRIOBP gene
(NM_001039141) was performed on genomic DNA from these 28 cases
using next-generation whole exome sequencing (WES). Only rare, non-
synonymous variants with a minor allele frequency (MAF) of ≤0.005% in
the genome aggregation database (gnomAD) (Lek et al., 2016) were
considered to be putatively pathogenic.
Statistics
Statistical significance was taken at P<0.05 as determined with a
Student’s t-test. Data are reported as mean±s.e.m. Statistical power
to ensure sufficient n-values was verified with Origin software.
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